Skip to main content

RA CAPITAL MANAGEMENT, L.P.

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1346824 BOSTON, MA

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$207,550,395
-$846,202 QoQ
Shares Held
7,692,750
0.0% QoQ
Ownership
8.70%
of shares outstanding
% of Portfolio
1.83%
of 13F equity value
Holder Rank
#2
of 224 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. MLYS ranks #12 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MLYS

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $207,550,395 7,692,750
2026-03-31 $208,396,597 7,692,750
2025-12-31 $265,778,887 7,323,750
2025-09-30 $277,716,600 7,323,750
2025-09-04 $258,217,860 7,796,433
2025-06-30 $83,172,698 6,147,280
2025-03-31 $97,618,806 6,147,280
2025-03-13 $84,882,559 6,287,597
2024-12-31 $59,715,613 4,850,984
2024-09-30 $58,745,416 4,850,984
2024-06-30 $56,756,512 4,850,984
2024-03-31 $62,626,203 4,850,984
2023-12-31 $27,334,893 3,178,476
2023-09-30 $30,227,306 3,178,476
2023-06-30 $54,193,015 3,178,476
2023-03-31 $49,774,934 3,178,476